HB2529 - Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.
Texas - 88th Legislature Regular Session
Introduced byJames Talarico
Last updated over 1 year ago
1 Co-Sponsor
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now